Study: CBD and Exercise Combo Improves Key Metabolic Markers in Obesity

Key Points
  • The study found that combining cannabidiol (CBD) with regular exercise improved several metabolic and inflammation-related markers in obese rats, suggesting potential benefits for obesity treatment strategies.
  • The experiment involved 40 obese rats divided into five groups, with interventions including exercise, CBD, and their combination over six weeks, showing significant differences in body mass index and blood sugar levels.
  • Significant changes were observed in gene expression related to metabolic and cellular stress pathways (LKB1 and PERK) in liver and adipose tissues, especially in the combined exercise and CBD group, although full recovery to non-obese levels was not achieved.
  • The researchers conclude that regular exercise combined with controlled CBD doses may improve metabolic health linked to obesity, warranting further studies, particularly in humans, to confirm these findings.

A new study published in BMC Sports Science, Medicine and Rehabilitation found that combining cannabidiol with regular exercise may improve several metabolic and inflammation-related markers in an animal model of obesity, suggesting the pairing could have potential in future obesity-related treatment strategies. The research was conducted by scientists from Kocaeli University and Firat University and examined how exercise, CBD and the combination of both affected gene expression tied to metabolic regulation in rats made obese through a high-fat diet.

The randomized controlled experiment involved 40 male Sprague-Dawley rats, all 8 weeks old, divided into five groups of eight. Those groups included a control group, an obese control group, an obese exercise group, an obese CBD group and an obese exercise-plus-CBD group. The intervention lasted six weeks and involved swimming exercise for 30 minutes a day, five days a week, along with oral CBD given at 10 milligrams per kilogram per day.

Researchers found significant differences between the groups in both body mass index and blood sugar levels following the six-week intervention. In liver tissue, the study found significant differences in the expression of LKB1 and PERK, two targets involved in metabolic and cellular stress pathways, while no significant difference was found for SREB1. In adipose tissue, LKB1 and PERK also showed significant differences, while SREB1 again did not reach statistical significance.

According to the study, the most notable improvements were seen in the intervention groups when compared to the obese control group, particularly when exercise and CBD were used together. Researchers said the combined intervention appeared to produce broader benefits in the target genes they examined than either strategy alone.

Even so, the study notes that the intervention groups did not fully return to the same levels as the non-obese control group, indicating that complete recovery was not achieved over the six-week period.

The researchers conclude that regular exercise combined with controlled doses of CBD may help improve metabolic health parameters linked to obesity. They say the findings support further research into using exercise alongside natural bioactive compounds as part of obesity prevention or treatment strategies.

Because the study was conducted in rats rather than humans, more research will be needed to determine whether the same effects translate to people. Still, the findings add to a growing body of research indicating that CBD may have therapeutic potential when used alongside other health-focused interventions rather than in isolation.